Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-01 Sale | 2022-02-03 5:31 pm | Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer | 968 | $16.65 | $16,117 | 30,968 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-02 Option Award | 2023-02-03 4:58 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer | 17,000 | $28.55 | 17,000 (Direct) | View |
| 2022-01-31 Other | 2022-02-03 5:31 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer | 968 | $12.39 | 30,968 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 5:31 pm | N/A 2032-02-02 | Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer | 30,000 | $15.79 | 30,968 (Direct) | View |
Ownership | 2021-11-04 4:03 pm | N/A 2031-02-03 | Syndax Pharmaceuticals Inc | SNDX | Nolte Alexander Chief Accounting Officer | 0 | $0 | 156,667 (Direct) | View |